De-Risking Raw & Starting Material Supply: Building Flexible, Standardized, & Resilient Strategies for Viral Vector Manufacturing
- Extending supply chain risk mapping to strengthen continuity of critical raw and starting materials
- Exploring collaborative inventory models to bridge shortages and prevent delays to batch release and clinical timelines
- Standardizing materials across products to streamline inventory, lower cost and accelerate procurement